NAPSA and prostate carcinoma: In this case, the initial suspicion of prostate cancer was ruled out through comprehensive immunohistochemical (IHC) analysis, which revealed the absence of prostate-specific markers (PSA, NKX3.1) and the presence of lung-specific markers (TTF-1, Napsin A) in the prostate biopsy.